Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis
Writing Group for the CKD Prognosis Consortium,Morgan E Grams,Josef Coresh,Kunihiro Matsushita,Shoshana H Ballew,Yingying Sang,Aditya Surapaneni,Natalia Alencar de Pinho,Amanda Anderson,Lawrence J Appel,Johan Ärnlöv,Fereidoun Azizi,Nisha Bansal,Samira Bell,Henk J G Bilo,Nigel J Brunskill,Juan J Carrero,Steve Chadban,John Chalmers,Jing Chen,Elizabeth Ciemins,Massimo Cirillo,Natalie Ebert,Marie Evans,Alejandro Ferreiro,Edouard L Fu,Masafumi Fukagawa,Jamie A Green,Orlando M Gutierrez,William G Herrington,Shih-Jen Hwang,Lesley A Inker,Kunitoshi Iseki,Tazeen Jafar,Simerjot K Jassal,Vivekanand Jha,Aya Kadota,Ronit Katz,Anna Köttgen,Tsuneo Konta,Florian Kronenberg,Brian J Lee,Jennifer Lees,Adeera Levin,Helen C Looker,Rupert Major,Cheli Melzer Cohen,Makiko Mieno,Mariko Miyazaki,Olivier Moranne,Isao Muraki,David Naimark,Dorothea Nitsch,Wonsuk Oh,Michelle Pena,Tanjala S Purnell,Charumathi Sabanayagam,Michihiro Satoh,Simon Sawhney,Elke Schaeffner,Ben Schöttker,Jenny I Shen,Michael G Shlipak,Smeeta Sinha,Benedicte Stengel,Keiichi Sumida,Marcello Tonelli,Jose M Valdivielso,Arjan D van Zuilen,Frank L J Visseren,Angela Yee-Moon Wang,Chi-Pang Wen,David C Wheeler,Hiroshi Yatsuya,Kunihiro Yamagata,Jae Won Yang,Ann Young,Haitao Zhang,Luxia Zhang,Andrew S Levey,Ron T Gansevoort,Morgan Grams,Mark Woodward,Katie Harris,Hisatomi Arima,Koji Tamakoshi,Yuanying Li,Kevan Polkinghorne,Ognjenka Djurdjev,Mila Tang,Fang Wang,Jinwei Wang,Ming-Hui Zhao,Nina Mielke,Anita Lloyd,Frank Sacks,Mark Sarnak,Kazumasa Yamagishi,Yuji Shimizu,Hiroyasu Iso,Shoichi Maruyama,Takayuki Hamano,Naohiko Fujii,Takahiro Imaizumi,Natalia Alencar De Pinho,Marie Metzger,Bénédicte Stengel,Aghilès Hamroun,Ziad Massy,Tazeen H Jafar,Imtiaz Jehan,Juanita Hatcher,Nish Chaturvedi,Neil Poulter,Martin Landray,James Lash,Jon Taliercio,Peter Wei Yang,Katherine Tuttle,Radica Alicic,Susanne Nicholas,Jenny Shen,Hannah Stocker,Dietrich Rothenbacher,Hermann Brenner,Daniel Levy,Markus P Schneider,Heike Meiselbach,Kai-Uwe Eckardt,Alexander R Chang,H Lester Kirchner,Gurmukteshwar Singh,Corri Black,Katie Wilde,Angharad Marks,Moneeza Siddiqui,Colin Palmer,Ewan Pearson,Masaaki Nakayama,Tae Yamamoto,Gen Yamada,Sadayoshi Ito,Henry Hon-Lin Wu,Hoi Ching Cheung,Victoria Ngai,Tang Ka Tak,Amit X Garg,Eric McArthur,Ashok Kumar Yadav,Vivek Kumar,April P Carson,Bessie A Young,Clarissa Diamantidis,Yuan-I Min,Shizukiyo Ishikawa,Koichi Asahi,Laura Gray,James Medcalf,Gabriel Chodick,Jack Fm Wetzels,Peter J Blankestijn,Joachim Ix,Ian de Boer,Barbara Kollerits,Eberhard Ritz,Girish N Nadkarni,Lili Chan,Erwin P Bottinger,Zhihong Liu,Lihua Zhang,Marcelino Bermudez-Lopez,Milica Bozic,Maite Caus,Juan Miguel Diaz-Tocados,Katsuyuki Miura,Hirotsugu Ueshima,Akira Okayama,Tomonori Okamura,Laura Sola,Jose Santiago,Pablo Rios,Liliana Gadola,Ricardo Silvariño,Takayoshi Ohkubo,Hirohito Metoki,Masahiro Kikuya,Jeff Mohl,Robert G Nelson,Robert L Hanson,Lyanne M Kieneker,Stephan Jl Bakker,Cecile Couchoud,David Shepherd,Jaclyn Bergstrom,Csaba P Kovesdy,Prabin Shrestha,Orlando Gutierrez,Katharine Cheung,Paul Muntner,Titi Ilori,Hiddo Jl Heerspink,Carl-Gustaf Elinder,Peter Barany,Ching-Yu Cheng,Tien Yin Wong,Crystal Chong Chun Yuen,William Herrington,Natalie Staplin,Martin J Landray,Colin Baigent,Philip Kalra,Rajkumar Chinnadurai,Darren Green,James Ritchie,Frank Lj Visseren,Pascal Burger,Marielle Emmelot,Berend van Welzen,Oommen John,Balaji Gummidi,Arpita Ghosh,Navdeep Tangri,Min-Kuang Tsai,Yoshiyuki Ueno,Masafumi Watanabe,Kazunobu Ichikawa,Mohammadhassan Mirbolouk,Farzad Hadaegh,Farhad Hosseinpanah,Wen Shi,Dan Arking,Anders Larsson,Vilmantas Giedraitis,Patrick Mark,Jamie Traynor,Michael Sullivan,Jae Il Shin,Jun Young Lee,Jae Seok Kim,Henk Jg Bilo,Peter van Dijk,Mireille Edens,Joep Dille,Juan-Jesus Carrero,Jingsha Chen
DOI: https://doi.org/10.1001/jama.2023.17002
IF: 11.816
2023-10-03
JAMA
Abstract:Importance: Chronic kidney disease (low estimated glomerular filtration rate [eGFR] or albuminuria) affects approximately 14% of adults in the US. Objective: To evaluate associations of lower eGFR based on creatinine alone, lower eGFR based on creatinine combined with cystatin C, and more severe albuminuria with adverse kidney outcomes, cardiovascular outcomes, and other health outcomes. Design, setting, and participants: Individual-participant data meta-analysis of 27 503 140 individuals from 114 global cohorts (eGFR based on creatinine alone) and 720 736 individuals from 20 cohorts (eGFR based on creatinine and cystatin C) and 9 067 753 individuals from 114 cohorts (albuminuria) from 1980 to 2021. Exposures: The Chronic Kidney Disease Epidemiology Collaboration 2021 equations for eGFR based on creatinine alone and eGFR based on creatinine and cystatin C; and albuminuria estimated as urine albumin to creatinine ratio (UACR). Main outcomes and measures: The risk of kidney failure requiring replacement therapy, all-cause mortality, cardiovascular mortality, acute kidney injury, any hospitalization, coronary heart disease, stroke, heart failure, atrial fibrillation, and peripheral artery disease. The analyses were performed within each cohort and summarized with random-effects meta-analyses. Results: Within the population using eGFR based on creatinine alone (mean age, 54 years [SD, 17 years]; 51% were women; mean follow-up time, 4.8 years [SD, 3.3 years]), the mean eGFR was 90 mL/min/1.73 m2 (SD, 22 mL/min/1.73 m2) and the median UACR was 11 mg/g (IQR, 8-16 mg/g). Within the population using eGFR based on creatinine and cystatin C (mean age, 59 years [SD, 12 years]; 53% were women; mean follow-up time, 10.8 years [SD, 4.1 years]), the mean eGFR was 88 mL/min/1.73 m2 (SD, 22 mL/min/1.73 m2) and the median UACR was 9 mg/g (IQR, 6-18 mg/g). Lower eGFR (whether based on creatinine alone or based on creatinine and cystatin C) and higher UACR were each significantly associated with higher risk for each of the 10 adverse outcomes, including those in the mildest categories of chronic kidney disease. For example, among people with a UACR less than 10 mg/g, an eGFR of 45 to 59 mL/min/1.73 m2 based on creatinine alone was associated with significantly higher hospitalization rates compared with an eGFR of 90 to 104 mL/min/1.73 m2 (adjusted hazard ratio, 1.3 [95% CI, 1.2-1.3]; 161 vs 79 events per 1000 person-years; excess absolute risk, 22 events per 1000 person-years [95% CI, 19-25 events per 1000 person-years]). Conclusions and relevance: In this retrospective analysis of 114 cohorts, lower eGFR based on creatinine alone, lower eGFR based on creatinine and cystatin C, and more severe UACR were each associated with increased rates of 10 adverse outcomes, including adverse kidney outcomes, cardiovascular diseases, and hospitalizations.